In Person

4th Annual International Cannabinoid Derived Pharmaceuticals Summit

September 21 – 23, 2021
Event details
September 21 – 23, 2021
12:00 – 12:00 am Eastern Standard Time
401-403 D Street Boston, Massachusetts

Event summary

Returning for its 4th year, the Cannabinoid Derived Pharmaceuticals Summit is comprehensively addressing the industry’s key challenges all the way from bench to bedside, ensuring cannabinoid therapeutics fulfill their true potential.

With dozens of clinical opportunities having been identified as potential targets for cannabinoid therapy and with current therapeutics failing to serve a vast array of unmet clinical needs, the burgeoning field of cannabinoid pharmaceuticals is gathering pace. This year’s agenda takes aims to overcome the exciting new challenges, discuss ongoing issues that are yet to be addressed and set the tone and direction for the next 12 months of development. By providing the only platform for discussion of issues present in CDP development from bench to bedside. This meeting is the most comprehensive assembly of cannabinoid pharmaceutical specialists targeting the issues important to bringing the next generation of CDPs to market.

For more information, please email Seema Desai.

Featured agenda item

Protecting Your Work with Strong Intellectual Property Strategy

Thursday, September 23, 2021: 2:00 pm ET

Cooley lawyers Dan Knauss, Erich Veitenheimer and Marcelo Pomeranz will speak during this session

Topics include

  • Hear perspectives on IP strategy and enforcement from key opinion leaders at the heart of the cannabis and cannabinoid field
  • Understand the IP lifecycle, and how work at one stage can influence another. What things your team can do during prosecution to prepare a company for litigation

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.